Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03679247 · ClinicalTrials.gov registry record · NA
Electronic Tools to Increase Recognition and Improve Primary Care Management for Hypertension in Chronic Kidney Disease
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 2,026
- Enrollment target
NCT03679247: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT03679247 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 2,026 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03679247, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,026 participants
- Enrollment target
Study Summary
In this project the investigators will create computer reminders through user-centered design and will validate the logic using retrospective electronic health record (EHR) data. Then the investigators will test the reminders in primary care clinics to see if they improve treatment of high blood pressure in early chronic kidney disease. Hypothesis: The mean systolic blood pressure of the chronic kidney disease (CKD) population can be decreased by an intervention with three innovative features: 1) methods to synthesize EHR data in order to identify under-diagnosed chronic conditions, 2) iterative improvement in clinical decision support (CDS) content through human factors methods to maximize the "informativeness" of the CDS, and 3) the use of behavioral economic principles to create behavioral "nudges" internal and external to the CDS.
Primary Outcome
Difference in SBP from baseline to 180 days
Interventions
- OTHER Control
- OTHER Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,026 participants |
| Start Date | 2021-02-26 |
| Est. Completion | 2022-10-26 |
| Phase | NA |
What the finished NCT03679247 record still lists
NCT03679247 is an interventional study that assigns participants to a tested intervention. Its 2,026 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% higher).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03679247 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03679247 about?
NCT03679247 is a clinical study titled "Electronic Tools to Increase Recognition and Improve Primary Care Management for Hypertension in Chronic Kidney Disease". In this project the investigators will create computer reminders through user-centered design and will validate the logic using retrospective electronic health record (EHR) data. Then the investigators will test the reminders in primary care clinics to see if they improve treatment of high blood pre...
What is the current status of trial NCT03679247?
This trial is currently completed. It is a NA study. The enrollment target is 2,026 participants. The study started on 2021-02-26. Estimated completion is 2022-10-26.
What interventions are being tested in trial NCT03679247?
The interventions under investigation include: Control (OTHER), Intervention (OTHER).
Who is sponsoring clinical trial NCT03679247?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03679247's enrollment target sits among peer trials
2,026 52nd of 2000 higher than 1,949 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04216732 · 2,030 participants
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
- NCT05625659 · 2,032 participants · NA
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
- NCT05059444 · 2,020 participants
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- NCT06825897 · 2,039 participants · NA
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI